Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Small Cell Lung Carcinoma 6Carcinoma, Non-Small-Cell Lung 2Carcinoma, Neuroendocrine 2Solid Tumors 1Solid Tumor Cancer 1Progression Free Survival 1Intracranial Germ Cell CNS Tumor, Childhood 1Hormone Refractory Prostate Cancer 1Carcinoma 1

Interventions

Etoposide 2Cisplatin 2osimertinib 1apatinib 1S 1 (combination) 1PE regimen 1Docetaxel 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Progression Free Survival × PE regimen × Clear all
NCT03100955 2017-04-04

A Study of Standard Treatment +/- Apatinib in Extensive Stage Small Cell Lung Cancer

Qingdao University

Phase 3 Unknown
120 enrolled

Progression Free Survival

Data powered by HemOnc (CC BY 4.0) Colophon âš¡